201 related articles for article (PubMed ID: 24586443)
1. S100A9 knockout decreases the memory impairment and neuropathology in crossbreed mice of Tg2576 and S100A9 knockout mice model.
Kim HJ; Chang KA; Ha TY; Kim J; Ha S; Shin KY; Moon C; Nacken W; Kim HS; Suh YH
PLoS One; 2014; 9(2):e88924. PubMed ID: 24586443
[TBL] [Abstract][Full Text] [Related]
2. S100a9 knockdown decreases the memory impairment and the neuropathology in Tg2576 mice, AD animal model.
Ha TY; Chang KA; Kim Ja; Kim HS; Kim S; Chong YH; Suh YH
PLoS One; 2010 Jan; 5(1):e8840. PubMed ID: 20098622
[TBL] [Abstract][Full Text] [Related]
3. The role of S100a9 in the pathogenesis of Alzheimer's disease: the therapeutic effects of S100a9 knockdown or knockout.
Chang KA; Kim HJ; Suh YH
Neurodegener Dis; 2012; 10(1-4):27-9. PubMed ID: 22301734
[TBL] [Abstract][Full Text] [Related]
4. Alzheimer's disease amyloid-β pathology in the lens of the eye.
Moncaster JA; Moir RD; Burton MA; Chadwick O; Minaeva O; Alvarez VE; Ericsson M; Clark JI; McKee AC; Tanzi RE; Goldstein LE
Exp Eye Res; 2022 Aug; 221():108974. PubMed ID: 35202705
[TBL] [Abstract][Full Text] [Related]
5. Prevention of age-related spatial memory deficits in a transgenic mouse model of Alzheimer's disease by chronic Ginkgo biloba treatment.
Stackman RW; Eckenstein F; Frei B; Kulhanek D; Nowlin J; Quinn JF
Exp Neurol; 2003 Nov; 184(1):510-20. PubMed ID: 14637120
[TBL] [Abstract][Full Text] [Related]
6. Fruitless Wolfberry-Sprout Extract Rescued Cognitive Deficits and Attenuated Neuropathology in Alzheimer's Disease Transgenic Mice.
Liu SY; Lu S; Yu XL; Yang SG; Liu W; Liu XM; Wang SW; Zhu J; Ji M; Liu DQ; Zhang ZP; Liu RT
Curr Alzheimer Res; 2018; 15(9):856-868. PubMed ID: 29623840
[TBL] [Abstract][Full Text] [Related]
7. Cerebral inoculation of human A53T α-synuclein reduces spatial memory decline and amyloid-β aggregation in APP/PS1 transgenic mice of Alzheimer's disease.
Hao YN; Lu QX; Zhai YH; Wang HY; Wu MN; Hu MM; Yang B; Wang ZJ; Wu ZW; Qi JS
Brain Res Bull; 2018 Oct; 143():116-122. PubMed ID: 30366065
[TBL] [Abstract][Full Text] [Related]
8. Effect of Proinflammatory S100A9 Protein on Migration and Proliferation of Microglial Cells.
Bai Q; Sun D; Zeng Y; Zhu J; Zhang C; Zhang X; Chen L; Zhou X; Ye L; Tang Y; Liu Y; Morozova-Roche LA
J Mol Neurosci; 2023 Dec; 73(11-12):983-995. PubMed ID: 37947991
[TBL] [Abstract][Full Text] [Related]
9. Icariin decreases both APP and Aβ levels and increases neurogenesis in the brain of Tg2576 mice.
Li F; Dong HX; Gong QH; Wu Q; Jin F; Shi JS
Neuroscience; 2015 Sep; 304():29-35. PubMed ID: 26079110
[TBL] [Abstract][Full Text] [Related]
10. Isorhynchophylline ameliorates cognitive impairment via modulating amyloid pathology, tau hyperphosphorylation and neuroinflammation: Studies in a transgenic mouse model of Alzheimer's disease.
Li HQ; Ip SP; Yuan QJ; Zheng GQ; Tsim KKW; Dong TTX; Lin G; Han Y; Liu Y; Xian YF; Lin ZX
Brain Behav Immun; 2019 Nov; 82():264-278. PubMed ID: 31476414
[TBL] [Abstract][Full Text] [Related]
11. Chronic administration of R-flurbiprofen attenuates learning impairments in transgenic amyloid precursor protein mice.
Kukar T; Prescott S; Eriksen JL; Holloway V; Murphy MP; Koo EH; Golde TE; Nicolle MM
BMC Neurosci; 2007 Jul; 8():54. PubMed ID: 17650315
[TBL] [Abstract][Full Text] [Related]
12. IL-6 trans-signaling in the brain influences the behavioral and physio-pathological phenotype of the Tg2576 and 3xTgAD mouse models of Alzheimer's disease.
Escrig A; Canal C; Sanchis P; Fernández-Gayol O; Montilla A; Comes G; Molinero A; Giralt M; Giménez-Llort L; Becker-Pauly C; Rose-John S; Hidalgo J
Brain Behav Immun; 2019 Nov; 82():145-159. PubMed ID: 31401302
[TBL] [Abstract][Full Text] [Related]
13. Reduction of amyloid-β deposition and attenuation of memory deficits by tolfenamic acid.
Subaiea GM; Ahmed AH; Adwan LI; Zawia NH
J Alzheimers Dis; 2015; 43(2):425-33. PubMed ID: 25096618
[TBL] [Abstract][Full Text] [Related]
14. Transthyretin accelerates vascular Abeta deposition in a mouse model of Alzheimer's disease.
Wati H; Kawarabayashi T; Matsubara E; Kasai A; Hirasawa T; Kubota T; Harigaya Y; Shoji M; Maeda S
Brain Pathol; 2009 Jan; 19(1):48-57. PubMed ID: 18429966
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of extracellular signal-regulated kinase activity improves cognitive function in Tg2576 mice.
Jin P; Choi DY; Hong JT
Clin Exp Pharmacol Physiol; 2012 Oct; 39(10):852-7. PubMed ID: 23013130
[TBL] [Abstract][Full Text] [Related]
16. Deletion of the cathepsin B gene improves memory deficits in a transgenic ALZHeimer's disease mouse model expressing AβPP containing the wild-type β-secretase site sequence.
Kindy MS; Yu J; Zhu H; El-Amouri SS; Hook V; Hook GR
J Alzheimers Dis; 2012; 29(4):827-40. PubMed ID: 22337825
[TBL] [Abstract][Full Text] [Related]
17. Amyloid-β plaque formation and reactive gliosis are required for induction of cognitive deficits in App knock-in mouse models of Alzheimer's disease.
Sakakibara Y; Sekiya M; Saito T; Saido TC; Iijima KM
BMC Neurosci; 2019 Mar; 20(1):13. PubMed ID: 30894120
[TBL] [Abstract][Full Text] [Related]
18. 4-O-methylhonokiol prevents memory impairment in the Tg2576 transgenic mice model of Alzheimer's disease via regulation of β-secretase activity.
Lee YJ; Choi DY; Lee YK; Lee YM; Han SB; Kim YH; Kim KH; Nam SY; Lee BJ; Kang JK; Yun YW; Oh KW; Hong JT
J Alzheimers Dis; 2012; 29(3):677-90. PubMed ID: 22330831
[TBL] [Abstract][Full Text] [Related]
19. Acetylcholinesterase inhibitors ameliorate behavioral deficits in the Tg2576 mouse model of Alzheimer's disease.
Dong H; Csernansky CA; Martin MV; Bertchume A; Vallera D; Csernansky JG
Psychopharmacology (Berl); 2005 Aug; 181(1):145-52. PubMed ID: 15778881
[TBL] [Abstract][Full Text] [Related]
20. Reduction of advanced tau-mediated memory deficits by the MAP kinase p38γ.
Ittner A; Asih PR; Tan ARP; Prikas E; Bertz J; Stefanoska K; Lin Y; Volkerling AM; Ke YD; Delerue F; Ittner LM
Acta Neuropathol; 2020 Sep; 140(3):279-294. PubMed ID: 32725265
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
